186 related articles for article (PubMed ID: 34255859)
1. Predicting mortality and no-reflow in STEMI patients using epicardial adipose tissue.
Mohamed A
Clin Cardiol; 2021 Oct; 44(10):1371-1376. PubMed ID: 34255859
[TBL] [Abstract][Full Text] [Related]
2. The relationship between epicardial adipose tissue and ST-segment resolution in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Zencirci E; Zencirci AE; Değirmencioğlu A; Karakuş G; Uğurlucan M; Özden K; Erdem A; Güllü AÜ; Ekmekçi A; Velibey Y; Erer HB; Çelik S; Akyol A
Heart Vessels; 2015 Mar; 30(2):147-53. PubMed ID: 24413852
[TBL] [Abstract][Full Text] [Related]
3. Coronary artery ectasia, an independent predictor of no-reflow after primary PCI for ST-elevation myocardial infarction.
Schram HCF; Hemradj VV; Hermanides RS; Kedhi E; Ottervanger JP;
Int J Cardiol; 2018 Aug; 265():12-17. PubMed ID: 29731349
[TBL] [Abstract][Full Text] [Related]
4. Echocardiographic epicardial fat thickness is a predictor for target vessel revascularization in patients with ST-elevation myocardial infarction.
Park JS; Lee YH; Seo KW; Choi BJ; Choi SY; Yoon MH; Hwang GS; Tahk SJ; Shin JH
Lipids Health Dis; 2016 Nov; 15(1):194. PubMed ID: 27852304
[TBL] [Abstract][Full Text] [Related]
5. Relationship between epicardial adipose tissue thickness and coronary thrombus burden in patients with ST-elevation myocardial infarction.
Uslu A; Kup A; Dogan C; Sari M; Cersit S; Aksu U; Kanat S; Demir M; Tenekecioglu E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Jun; 164(2):141-146. PubMed ID: 31544899
[TBL] [Abstract][Full Text] [Related]
6. The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.
Süleymanoğlu M; Rencüzoğulları İ; Karabağ Y; Çağdaş M; Yesin M; Gümüşdağ A; Çap M; Gök M; Yıldız İ
Int J Cardiovasc Imaging; 2020 May; 36(5):789-796. PubMed ID: 31919706
[TBL] [Abstract][Full Text] [Related]
7. In-Hospital Peak Glycemia in Predicting No-Reflow Phenomenon in Diabetic Patients with STEMI Treated with Primary Percutaneous Coronary Intervention.
Liu F; Huang R; Li Y; Zhao S; Gong Y; Xu Z
J Diabetes Res; 2021; 2021():6683937. PubMed ID: 33506051
[TBL] [Abstract][Full Text] [Related]
8. Morphological predictors for no reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction caused by plaque rupture.
Soeda T; Higuma T; Abe N; Yamada M; Yokoyama H; Shibutani S; Ong DS; Vergallo R; Minami Y; Lee H; Okumura K; Jang IK
Eur Heart J Cardiovasc Imaging; 2017 Jan; 18(1):103-110. PubMed ID: 26800769
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
10. Coronary perivascular epicardial adipose tissue and major adverse cardiovascular events after ST segment-elevation myocardial infarction.
Toya T; Corban MT; Imamura K; Bois JP; Gulati R; Oh JK; Lerman LO; Lerman A
Atherosclerosis; 2020 Jun; 302():27-35. PubMed ID: 32417697
[TBL] [Abstract][Full Text] [Related]
11. Association between epicardial adipose tissue volume and myocardial salvage in patients with a first ST-segment elevation myocardial infarction: An epicardial adipose tissue paradox.
Gohbara M; Iwahashi N; Akiyama E; Maejima N; Tsukahara K; Hibi K; Kosuge M; Ebina T; Umemura S; Kimura K
J Cardiol; 2016 Nov; 68(5):399-405. PubMed ID: 27004962
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of the No-Reflow Phenomenon and Epicardial Adipose Tissue for Clinical Outcomes After Primary Percutaneous Coronary Intervention.
Zencirci AE; Zencirci E; Değirmencioğlu A; Erdem A; Karakuş G; Özden K; Karadeniz F; Buturak A; Belen E; Tipi F; Eren M
Hellenic J Cardiol; 2015; 56(4):311-9. PubMed ID: 26233771
[TBL] [Abstract][Full Text] [Related]
13. The relationship between serum rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Quisi A; Alıcı G
J Clin Lab Anal; 2018 Nov; 32(9):e22598. PubMed ID: 29943408
[TBL] [Abstract][Full Text] [Related]
14. CHA2DS2-VASc Score is a Predictor of No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Intervention.
Ipek G; Onuk T; Karatas MB; Gungor B; Osken A; Keskin M; Oz A; Tanik O; Hayiroglu MI; Yaka HY; Ozturk R; Bolca O
Angiology; 2016 Oct; 67(9):840-5. PubMed ID: 26685178
[TBL] [Abstract][Full Text] [Related]
15. Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Aitmokhtar O; Paganelli F; Benamara S; Azaza A; Bonello L; Hamza O; Seddiki S; Benathmane T; Saidane M; Bouzid A; Kara M; Sik A; Azzouz A; Harbi F; Monsuez JJ; Benkhedda S
Arch Cardiovasc Dis; 2017 Nov; 110(11):626-633. PubMed ID: 28583820
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Zhao Y; Yang J; Ji Y; Wang S; Wang T; Wang F; Tang J
Heart Vessels; 2019 Oct; 34(10):1600-1607. PubMed ID: 30993442
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
Kurtul A; Acikgoz SK
Am J Cardiol; 2017 Aug; 120(4):534-541. PubMed ID: 28633762
[TBL] [Abstract][Full Text] [Related]
18. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Wang Z; Ren L; Liu N; Lei L; Ye H; Peng J
Kardiol Pol; 2016; 74(10):1160-1166. PubMed ID: 27160177
[TBL] [Abstract][Full Text] [Related]
19. Relationship between circulating miRNA-30e and no-reflow phenomenon in STEMI patients undergoing primary coronary intervention.
Su Q; Ye Z; Sun Y; Yang H; Li L
Scand J Clin Lab Invest; 2018 Jul; 78(4):318-324. PubMed ID: 29703083
[TBL] [Abstract][Full Text] [Related]
20. Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction.
Qi Q; Niu J; Chen T; Yin H; Wang T; Jiang Z
Med Sci Monit; 2018 May; 24():2767-2776. PubMed ID: 29726480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
